Boryung Pharmaceutical Co., Ltd: all 143 studies

Page 1 of 2. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.

• To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or 'Fimasartan, Atorvastatin and Ezetimibe'.Not yet recruitingNCT07685054
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed ConditionsNot yet recruitingNCT07421414Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting ConditionsNot yet recruitingNCT07421401Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed ConditionsNot yet recruitingNCT07421388Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting ConditionsNot yet recruitingNCT07421375Phase 1
• A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential HypertensionNot yet recruitingNCT07373613Phase 2
• A Study of Olanzapine in Participants With Bipolar Disorder.RecruitingNCT07263191
• A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.RecruitingNCT07263178
• A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.Not yet recruitingNCT07180771Phase 2
• A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)RecruitingNCT07083401Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)RecruitingNCT07083388Phase 1
• A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian CancerRecruitingNCT07069335Phase 1
• A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 DiabetesRecruitingNCT06972732Phase 4
• A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1RecruitingNCT06867497Phase 1
• A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With SchizophreniaRecruitingNCT06821945Phase 2
• A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination TherapyRecruitingNCT06649162
• A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer PatientsRecruitingNCT06537752
• A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/EzetimibRecruitingNCT06314919
• A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination TherapyRecruitingNCT06220773Phase 3
• A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.RecruitingNCT06126016
• Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ InjectionRecruitingNCT06021483
• A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and HypertensionRecruitingNCT05970237
• An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZRecruitingNCT05413057
• NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitisCompletedNCT04131686Results posted
• FimasaRtan-basEd BP Targets After Drug SwitcHingCompletedNCT03649646Results posted
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male SubjectsCompletedNCT02704702Phase 1Results posted
• Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)CompletedNCT02385721Results posted
• A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis PatientsCompletedNCT01499368Phase 3Results posted
• Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension PatientsCompletedNCT00922480Phase 3Results posted
• A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential HypertensionCompletedNCT00922441Phase 2Results posted
• A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fed ConditionsCompletedNCT06890299Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fasting ConditionsCompletedNCT06890286Phase 1
• A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult VolunteersCompletedNCT06889064Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult VolunteersCompletedNCT06889012Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fasting ConditionsCompletedNCT06879158Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed ConditionsCompletedNCT06879132Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed ConditionsCompletedNCT06744439Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fasting ConditionsCompletedNCT06744426Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting ConditionsCompletedNCT06744127Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers Fed ConditionsCompletedNCT06744062Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy VolunteersCompletedNCT06636877Phase 1
• A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult VolunteersCompletedNCT06289933Phase 1
• A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fasting Conditions in Healthy Adult VolunteersCompletedNCT06289920Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"CompletedNCT06226727Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"CompletedNCT06184269Phase 1
• A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018CCompletedNCT06165250Phase 3
• A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"CompletedNCT06165237Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fasting Conditions in Healthy VolunteersCompletedNCT06008028Phase 1
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy VolunteersCompletedNCT06008015Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fed Conditions in Healthy Adult VolunteersCompletedNCT05959499Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult VolunteersCompletedNCT05959486Phase 1
• A Study to Evaluate Drug-drug Interactions and Safety Between "BR3006-1", "BR3006-2", and "BR3006-3" in Healthy VolunteersCompletedNCT05951946Phase 1
• A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary HypercholesterolemiaCompletedNCT05930028Phase 3
• A Study to Evaluate the Efficacy and Safety of BR1015 Combination TherapyCompletedNCT05878561Phase 3
• A Clinical Trial Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1019-1 and BR1019-2 in Healthy Adult SubjectsCompletedNCT05875259Phase 1
• An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and SafetyCompletedNCT05788718
• An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and EzetimibeCompletedNCT05559606
• A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult SubjectsCompletedNCT05460364Phase 1
• A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.CompletedNCT05411965Phase 1
• A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy VolunteersCompletedNCT05372380Phase 1
• A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016A" With "BR1016B" in Healthy VolunteersCompletedNCT05102903Phase 1
• A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)CompletedNCT05102305
• A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016C" With "BR1016D" in Healthy VolunteersCompletedNCT05102266Phase 1
• A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy VolunteersCompletedNCT05097794Phase 1
• An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and ProteinuriaCompletedNCT05086549
• A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy VolunteersCompletedNCT05068193Phase 1
• A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male VolunteersCompletedNCT04889651Phase 1
• A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and DapagliflozinCompletedNCT04885712Phase 3
• A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult SubjectsCompletedNCT04857047Phase 1
• A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult SubjectsCompletedNCT04846998Phase 1
• Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapYCompletedNCT04789980
• Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disorders(BASIS)CompletedNCT04770454
• A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and DyslipidemiaCompletedNCT04554953
• Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating FactorCompletedNCT04545632
• A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.CompletedNCT04485585Phase 1
• A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy VolunteersCompletedNCT04462029Early Phase 1
• Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon CancerActive, not recruitingNCT04416490
• VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple MyelomaCompletedNCT04151615
• BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)CompletedNCT04018248Phase 1
• BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine CombinationCompletedNCT03991442Phase 3
• To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy SubjectsCompletedNCT03718611Phase 1
• To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)CompletedNCT03654677Phase 3
• To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A VaccineCompletedNCT03654664Phase 3
• Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male SubjectsCompletedNCT03629067Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy VolunteersCompletedNCT03609294Phase 1
• Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male SubjectsCompletedNCT03390465Phase 1
• A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03338426Phase 3
• Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE StudyCompletedNCT03254914
• A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male VolunteersCompletedNCT03250052Phase 1
• Fimasartan in the Senior SubjectsCompletedNCT03246555Phase 3
• Fimasartan Blood Pressure Lowering After Acute StrokeCompletedNCT03231293
• Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03156842Phase 3
• A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg TabletWithdrawnNCT03156127Phase 1
• A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/RosuvastatinCompletedNCT02995720Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.CompletedNCT02994745Phase 1
• A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male VolunteersCompletedNCT02920931Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male SubjectsCompletedNCT02920047Phase 1
• Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia ControlCompletedNCT02913794
• A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate TabletCompletedNCT02759224Phase 1
• A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of FimasartanCompletedNCT02620306Phase 3

← Boryung Pharmaceutical Co., Ltd overview and focus areas